Pfizer, US ink $5.29 billion deal for possible Covid-19 treatment

Pfizer asked the FDA on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections